Earnings Summary

Transmedics Group Inc’s revenue jumped 155.66% since last year same period to $52.47Mn in the Q2 2023. On a quarterly growth basis, Transmedics Group Inc has generated 26.26% jump in its revenue since last 3-months.

Transmedics Group Inc’s net profit jumped 91.31% since last year same period to $-1Mn in the Q2 2023. On a quarterly growth basis, Transmedics Group Inc has generated 62.03% jump in its net profits since last 3-months.

Transmedics Group Inc’s net profit margin jumped 96.6% since last year same period to -1.91% in the Q2 2023. On a quarterly growth basis, Transmedics Group Inc has generated 69.92% jump in its net profit margins since last 3-months.

Transmedics Group Inc’s earning per share (EPS) estimates for the current quarter stand at -0.3 - a 26.83% jump from last quarter’s estimates.

Transmedics Group Inc’s earning per share (EPS) estimates for the current year stand at -0.3.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Transmedics Group Inc’s return on assets (ROA) stands at -0.02.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Transmedics Group Inc’s return on equity (ROE) stands at -0.18.